Florence-Nightingale-Krankenhaus

Düsseldorf 40489

0 studies enrolling now · 4 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis — Completed